PDX model details
| PDX ID | 373M Cx | 
|---|---|
| Host Strain(and Source) | NSG Source: Monash University | 
| Host Strain Immune system Humanized | NO | 
| Host Type | Castrate | 
| Graft Site | Subcutaneous | 
| Current Generation (* indicates number of generations grown in Castrate host) | 12 (2*) | 
| Average PDX Generation Time (days +/- SEM) | 92 ± 8 | 
| Tumor preparation | Tumor solid | 
| Tumor Characterization Technology | Histology, IHC, STR profiling, targeted DNA sequencing, RNAseq | 
| Tumor confirmed not to be of Mouse/EBV origin | Yes; negative for CD45 and/or positive for human CK8/18 and/or human mitochondria by IHC | 
| Passage QA performed | Routine QA every 2-3 passages | 
| Associated meta data | |
| PDX model availability | Yes (fixed, frozen or cryopreserved tissue) | 
| Governance restriction for distribution | Available to investigators with appropriate ethics approvals, approved EOI from MURAL committee, and material transfer agreements | 
| Pubmed ID | 34413304 | 
| Markers | 373M Cx | 
|---|---|
| AR | N | 
| PSA | N | 
| PSMA | N | 
| NE | Y | 
| ERG | N | 
                        This table displays curated CNVs
                        
            
                    
                    
| PDX ID | Gene Symbol | CNV Log2 | CNV Copy | CNV Call | Experiments name | Platform | Reference genome | 
|---|---|---|---|---|---|---|---|
| 373M Cx | ARID2 | 0.524546 | 2.87696 | gain | MURAL Prostate Cancer PDX collection | Targeted Twist Panel | hg19 | 
| 373M Cx | KMT2D | 0.524546 | 2.87696 | gain | MURAL Prostate Cancer PDX collection | Targeted Twist Panel | hg19 | 
| 373M Cx | STAB2 | 0.521015 | 2.86993 | gain | MURAL Prostate Cancer PDX collection | Targeted Twist Panel | hg19 | 
| 373M Cx | SMAD2 | 0.533208 | 2.89429 | gain | MURAL Prostate Cancer PDX collection | Targeted Twist Panel | hg19 | 
| 373M Cx | MBD1 | 0.533208 | 2.89429 | gain | MURAL Prostate Cancer PDX collection | Targeted Twist Panel | hg19 | 
| 373M Cx | AKT3 | -0.761796 | 1.17952 | loss | MURAL Prostate Cancer PDX collection | Targeted Twist Panel | hg19 | 
| 373M Cx | ARID1A | -1.74377 | 0.597177 | loss | MURAL Prostate Cancer PDX collection | Targeted Twist Panel | hg19 | 
| 373M Cx | FANCD2 | -0.774474 | 1.1692 | loss | MURAL Prostate Cancer PDX collection | Targeted Twist Panel | hg19 | 
| 373M Cx | RAF1 | -0.774474 | 1.1692 | loss | MURAL Prostate Cancer PDX collection | Targeted Twist Panel | hg19 | 
| 373M Cx | PIK3R1 | -1.7597 | 0.590619 | loss | MURAL Prostate Cancer PDX collection | Targeted Twist Panel | hg19 | 
| 373M Cx | RB1 | -1.74553 | 0.596449 | loss | MURAL Prostate Cancer PDX collection | Targeted Twist Panel | hg19 | 
| 373M Cx | CDH1 | -0.768346 | 1.17418 | loss | MURAL Prostate Cancer PDX collection | Targeted Twist Panel | hg19 | 
| 373M Cx | ZFHX3 | -0.768346 | 1.17418 | loss | MURAL Prostate Cancer PDX collection | Targeted Twist Panel | hg19 | 
| 373M Cx | FANCA | -0.768346 | 1.17418 | loss | MURAL Prostate Cancer PDX collection | Targeted Twist Panel | hg19 | 
| 373M Cx | TP53 | -0.794273 | 1.15327 | loss | MURAL Prostate Cancer PDX collection | Targeted Twist Panel | hg19 | 
| 373M Cx | ERF | -7.71745 | 0.00950268 | homdel | MURAL Prostate Cancer PDX collection | Targeted Twist Panel | hg19 | 
Clinical Information
| Sample Number | 373M | 
|---|---|
| Sample Site | Liver | 
| Sample source | Biopsy | 
| Pathology Tumor Diagnosis | Mixed Adeno & Neuro | 
| Gleason Score | None | 
| Primary Gleason Score | None | 
| Secondary Gleason Score | None | 
| Tertiary Gleason Score | None | 
| ISUP Grade Group | |
| Tumor Grade | |
| D'Amico Risk Classification | |
| Tumor Volume (in cc) | 0.0 | 
| Treatment Prior to Specimen Collection | ADT | 
Patient Information
| Patient Number | 373 | 
|---|---|
| Sex | Male | 
| Diagnosis | Prostate Cancer | 
| PSA at diagnosis (ng/mL) | NA | 
| Consent to share data | |
| Patient Tumor Collection (Current Model) | |
|---|---|
| Tumour sample ID | 373M | 
| Patient Age (binned in 5 year age groups) | 65-69 | 
                        This table displays curated sequence variants
The table can be sorted by any field. However, please note that when you click on a column header to sort, there might be a brief delay
                    The table can be sorted by any field. However, please note that when you click on a column header to sort, there might be a brief delay
| PDX ID | Gene Symbol | Depth | ALT_FREQ | Consequence | Exon | GnomAD_AF | CADD_PHRED | Clinvar_clnsig | Platform | Experiments Name | Reference | Library Type | Instrument Type | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 373M Cx | RB1 | 49 | 1.0 | missense_variant,splice_region_variant | '15/27 | . | 33 | - | Targeted Twist Panel | MURAL Prostate Cancer PDX collection | hg19 | paired | NextSeq 500 | 
| 373M Cx | TP53 | 268 | 0.99 | missense_variant | '8/11 | 0 | 28.8 | Conflicting_interpretations_of_pathogenicity | Targeted Twist Panel | MURAL Prostate Cancer PDX collection | hg19 | paired | NextSeq 500 | 
| 373M Cx | MAP3K1 | 73 | 0.71 | inframe_insertion | '1/20 | 0 | . | - | Targeted Twist Panel | MURAL Prostate Cancer PDX collection | hg19 | paired | NextSeq 500 | 
| 373M Cx | MAP2K2 | 400 | 0.68 | missense_variant | '9/11 | . | 22 | - | Targeted Twist Panel | MURAL Prostate Cancer PDX collection | hg19 | paired | NextSeq 500 | 
| 373M Cx | ADAMTS7 | 235 | 0.5 | missense_variant | '7/24 | . | 26.3 | - | Targeted Twist Panel | MURAL Prostate Cancer PDX collection | hg19 | paired | NextSeq 500 | 
| 373M Cx | ABL1 | 501 | 0.47 | missense_variant | '11/11 | 0.00013 | 28.6 | not_provided | Targeted Twist Panel | MURAL Prostate Cancer PDX collection | hg19 | paired | NextSeq 500 | 
| 373M Cx | CDKN2B-AS1 | 346 | 0.42 | splice_donor_variant,non_coding_transcript_variant | . | . | 11.78 | - | Targeted Twist Panel | MURAL Prostate Cancer PDX collection | hg19 | paired | NextSeq 500 | 
| 373M Cx | MYO5A | 461 | 0.34 | missense_variant | '15/41 | 6.50E-05 | 24.4 | - | Targeted Twist Panel | MURAL Prostate Cancer PDX collection | hg19 | paired | NextSeq 500 | 
| 373M Cx | LRP1B | 295 | 0.33 | splice_donor_variant | . | . | 33 | - | Targeted Twist Panel | MURAL Prostate Cancer PDX collection | hg19 | paired | NextSeq 500 | 
| 373M Cx | XIRP2 | 447 | 0.32 | frameshift_variant | '3/11 | 0.0004841 | . | - | Targeted Twist Panel | MURAL Prostate Cancer PDX collection | hg19 | paired | NextSeq 500 | 
| 373M Cx | XPO1 | 401 | 0.3 | missense_variant | '15/25 | 4.47E-06 | 34 | Likely_pathogenic | Targeted Twist Panel | MURAL Prostate Cancer PDX collection | hg19 | paired | NextSeq 500 | 
| 373M Cx | SOS1 | 260 | 0.3 | missense_variant | '4/24 | 0.000114 | 32 | Uncertain_significance | Targeted Twist Panel | MURAL Prostate Cancer PDX collection | hg19 | paired | NextSeq 500 | 
| 373M Cx | SHH | 508 | 0.28 | missense_variant | '3/3 | . | 4.35 | - | Targeted Twist Panel | MURAL Prostate Cancer PDX collection | hg19 | paired | NextSeq 500 | 
                No information in Gene expression 
            
            
            
            
        
                No information in Drug dosing Table
            
            
            A
        web-based Atlas of Patient-Derived Xenografts
        of cancer patients:A resource of MURAL PDX data
 A
        web-based Atlas of Patient-Derived Xenografts
        of cancer patients:A resource of MURAL PDX data
      